Publication | Open Access

Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Pharmaceutical ScienceBiochemistryMedicineDiabetesGlycobiologyTherapeutic ActivitySelective SodiumStructure–activity Relationship StudiesPharmacologyPharmaceutical ChemistryDrug DiscoveryGlycosylation